Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Brain Functional Sector-guided Multi-target Continuous Theta Burst Stimulation Therapy for Aphasia After Stroke: a RCT

NCT05957445 is registered in ClinicalTrials.gov with Changping Laboratory as lead sponsor.

NCT NCT05957445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05957445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Brain Functional Sector-guided Multi-target Continuous Theta Burst Stimulation Therapy for Aphasia After Stroke: a RCT
Lead sponsor
Changping Laboratory
Phase
Not applicable
Overall status
Unknown status
Start date
August 23, 2023
Completion date
October 1, 2025
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

aphasia, stroke